Revolution Medicines, Inc.
RVMD
Pozycja w akcjach
#579
Revolution Medicines, Inc. is a precision oncology firm operating in the... Revolution Medicines, Inc. is a precision oncology firm operating in the clinical development stage, dedicated to creating innovative treatments that target novel pathways crucial for RAS-driven cancers. Its pipeline includes several promising drug candidates: RMC-4630, an SHP2 inhibitor, is currently undergoing Phase 1/2 clinical trials for various solid tumors, such as gynecological and colorectal cancers. The company's portfolio also features RMC-5845, a selective inhibitor designed to target SOS1, a protein responsible for activating RAS within cells, and RMC-5552, a highly selective inhibitor for hyperactive mTORC1 signaling found in cancerous cells. Further expanding its therapeutic arsenal, Revolution Medicines is advancing RMC-6291, which selectively inhibits mutated forms of KRASG12C(ON) and NRASG12C(ON). Another promising compound, RMC-6236, specifically targets and inhibits a range of active RAS(ON) variants. Its research efforts also encompass other active RAS inhibitors aimed at KRASG13C(ON) and KRASG12D(ON) mutations. Revolution Medicines has established a collaborative partnership with Sanofi to research and develop SHP2 inhibitors, a collaboration that includes the development of RMC-4630. Established in 2014, Revolution Medicines, Inc. operates from its corporate headquarters situated in Redwood City, California.
Cena akcji
$196.16
Kapitalizacja rynkowa
$42.04B
Zmiana (1 dzień)
7.69%
Zmiana (1 rok)
263.19%
Kraj
US
Handel Revolution Medicines, Inc. (RVMD)
Kategoria
Healthcare
Liczba akcji w obrocie dla Revolution Medicines, Inc. (RVMD)
Liczba akcji w obrocie na dzień June 2026: 210.89M
Zgodnie z najnowszymi raportami finansowymi i ceną akcji Revolution Medicines, Inc., aktualna liczba akcji w obrocie to 210.89M. Na koniec December 2023 firma posiadała 113.15M akcji w obrocie. Liczba akcji w obrocie jest zwykle kształtowana przez podziały akcji i skupy akcji.
Historia liczby akcji w obrocie dla Revolution Medicines, Inc. (RVMD) od 2017 do 2026
Akcje w obrocie na koniec każdego roku
| Rok | Akcje w obrocie | Zmień |
|---|---|---|
| 2026 (TTM) | 210.89M | 25.73% |
| 2024 | 167.74M | 48.24% |
| 2023 | 113.15M | 40.34% |
| 2022 | 80.63M | 10.74% |
| 2021 | 72.81M | 9.32% |
| 2020 | 66.60M | 82.60% |
| 2019 | 36.47M | 0.00% |
| 2018 | 36.47M | 0.00% |
| 2017 | 36.47M | 0.00% |
Akcje w obrocie dla podobnych firm lub konkurentów
| Firma | Akcje w obrocie | Różnica | Kraj |
|---|---|---|---|
| 253.90M | 20.39% |
US
|
|
| 396.00M | 87.77% |
US
|
|
| 478.91M | 127.09% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | -70.51% |
NL
|
